Trends in health care expenditure in U.S. adults with Diabetes: 2002-2011

Diabetes Care

Volumn 38, Issue 10, 2015, Pages 1844-1851

  Ozieh, Mukoso N ^a,b   Bishu, Kinfe G ^a,b   Dismuke, Clara E ^b,c   Egede, Leonard E ^a,b,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Health Equity and Rural Research Innovation Center (HEROIC) Charleston VA HSR andD COIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; COST UTILITY ANALYSIS; DIABETES MELLITUS; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE SURVEY; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; RETROSPECTIVE STUDY; TREND STUDY; UNITED STATES; ADOLESCENT; COST OF ILLNESS; ECONOMICS; HEALTH CARE DELIVERY; HEALTH INSURANCE; MIDDLE AGED; PATIENT ATTITUDE; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; COST OF ILLNESS; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; FEMALE; HEALTH EXPENDITURES; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84960945662     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0369     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA, U.S. Department of Health and Human Services, 2014.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-1046.
3. Menzin J, Korn JR, Cohen J, et al. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. J Manag Care Pharm 2010;16: 264-275.
4. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103:137-149.
5. Hoyert DL, Xu JQ. Deaths: Preliminary Data for 2011. National Vital Statistics Reports; 61(6). Hyattsville, MD, National Center for Health Statistics, 2012.
6. Chen R, Cheadle A, Johnson D, Duran B. US trends in receipt of appropriate diabetes clinical and self-care from 2001 to 2010 and racial/ethnic disparities in care. Diabetes Educ 2014;40: 756-766.
7. Lozano R, Naghavi M, Foreman K. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128.
8. Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 2012;35:1252-1257.
9. Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract 2014;103:150-160.
10. Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged $ 18 years in the United States for 2010 and projections through 2020. Chest 2015;147: 31-45.
11. National Heart, Lung, and Blood Institute. Direct and indirect economic costs of illness by major diagnosis, U.S., 2008. In NHLBI Fiscal Year 2008 Fact Book. Bethesda, MD, National Heart, Lung, and Blood Institute, National Institutes of Health, 2008.
12. Teerlink JR, Alburikan K, Metra M, Rodgers JE. Acute decompensated heart failure update. Curr Cardiol Rev 2015;11:53-62.
13. Davis K. Expenditures for Hypertension Among Adults Age 18 and Older, 2010: Estimates for the U.S. Civilian Noninstitutionalized Population. Rockville, MD, Agency for Healthcare Research and Quality, 2013 (Statistical Brief #404).
14. Meng YY, Pickett MC, Babey SH, Davis AC, Goldstein H. Diabetes tied to a third of California hospital stays, driving health care costs higher. Policy Brief UCLA Cent Health Policy Res 2014;(PB2014-3):1-7.
15. Moy E, Chang E, Barrett M; Centers for Disease Control and Prevention (CDC). Potentially preventable hospitalizations - United States, 2001-2009. MMWR Surveill Summ 2013; 62(Suppl.3):139-143.
16. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999;159:1873-1880.
17. Trogdon JG, Hylands T. Nationally representative medical costs of diabetes by time since diagnosis. Diabetes Care 2008;31:2307-2311.
18. Lee LJ, Yu AP, Cahill KE, et al. Direct and indirect costs among employees with diabetic retinopathy in the United States. Curr Med Res Opin 2008;24:1549-1559.
19. Zhuo X, Zhang P, Barker L, Albright A, Thompson TJ, Gregg E. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care 2014;37:2557-2564.
20. Li R, Bilik D, Brown MB, et al. Medical costs associated with type 2 diabetes complications and comorbidities. Am J Manag Care 2013;19:421-430.
21. Li R, Barker LE, Shrestha S, et al. Changes over time in high out-of-pocket health care burden in U.S. adults with diabetes, 2001-2011. Diabetes Care 2014;37:1629-1635.
22. Brown JB, Nichols GA, Glauber HS, Bakst AW. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 1999;22:1116-1124.
23. Agency for Healthcare Research and Quality (AHCRa). Medical Expenditure Panel Survey. 2011 Full Year Consolidated Data File 2013a. Available from http://meps.ahrq.gov/mepsweb/data-stats/download-data-files.jsp. Accessed 18 August 2014.
24. Fu AZ, Qiu Y, Radican L, Wells BJ. Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care 2009;32:2187-2192.
25. CPI Inflation Calculator. Washington, DC, U.S. Bureau of Labor Statistics. Available from http://data.bls.gov/cgi-bin/cpicalc.pl. Accessed 15 July 2015.
26. DeVoe JE, Tillotson CJ, Wallace LS. Children's receipt of health care services and family health insurance patterns. Ann Fam Med 2009;7:406-413.
27. Desai PR, Lawson KA, Barner JC, Rascati KL. Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients. J Manag Care Pharm 2013;19:468-477.
28. Agency for Healthcare Research and Quality (AHCRb). MEPS HC-036: 1996-2011 Pooled Linkage Variance Estimation File 2013b, MEPS file. Available from http://meps.ahrq.gov/data-stats/download-data/pufs/h36/h36u11doc.shtml. Accessed 18 August 2014.
29. Manning WG, Mullahy J. Estimating log models: To transform or not to transform? J Health Econ 2001;20:461-494.
30. Belotti F, Deb P, Norton EC, Manning WG. Estimating two-part models. Stata J 2015;15: 3-20.
31. Ku L. Health insurance coverage and medical expenditures of immigrants and native-born citizens in the United States. Am J Public Health 2009;99:1322-1328.
32. Barnett SBL, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 2011;127:145-152.
33. Duan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models for the demand for medical care. J Bus Econ Stat 1983;1:115-126.
34. McWilliams JM, Zaslavsky AM, Huskamp HA. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage. JAMA 2011; 306:402-409.
35. Zhang Y, Donohue JM, Lave JR, Gellad WF. The impact of Medicare Part D on medication treatment of hypertension. Health Serv Res 2011;46:185-198.
36. Adams AS, Madden JM, Zhang F, et al. Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage. Med Care 2014;52:695- 703.
37. Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare- Advantage products. Med Care 2010;48:409-417.
38. Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care 2012; 35:2533-2539.
39. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between selfreport questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004;57:1096- 1103.